| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/19/2004 | WO2004069260A1 Compositon comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometriosis |
| 08/19/2004 | WO2004069259A1 Remedy for diabetes |
| 08/19/2004 | WO2004069258A2 Use of the sgk gene family for diagnosis and therapy of cataracts and glaucoma |
| 08/19/2004 | WO2004069255A2 Use of quinazoline derivatives or other compounds for inhibiting dihydrofolate reduxtase; screening assay for the identification of novel therapeutics and their cellular targets |
| 08/19/2004 | WO2004069254A2 Use of dipyridamole or mopidamole for treatment and prevention of mmp-9-dependent disorders |
| 08/19/2004 | WO2004069253A1 Treatment of bacterial diseases of the respiratory organs by locally applying fluoroquinolones |
| 08/19/2004 | WO2004069252A1 Cabergoline for the prophylactic treatment of migraine |
| 08/19/2004 | WO2004069251A1 Regimen of administration for nelfinavir |
| 08/19/2004 | WO2004069248A1 Prodrugs for use a ophthalmic agents |
| 08/19/2004 | WO2004069247A1 Topical immunotherapy and compositions for use therein |
| 08/19/2004 | WO2004069246A1 Drug compositions comprising inhibitors of cholinesterase for treating senile dementia |
| 08/19/2004 | WO2004069244A1 Oxazolidinone derivatives n-substituted by a bicyclic ring, for use as antibacterial agents |
| 08/19/2004 | WO2004069243A1 Breast cancer resistance protein (bcrp) inhibitor |
| 08/19/2004 | WO2004069242A1 Anthelmintic composition |
| 08/19/2004 | WO2004069241A1 Therapeutic use of acylglycerols and the nitrogen- and sulphur-containing analogues thereof |
| 08/19/2004 | WO2004069240A2 Use in therapy of endocannabinoid-like compounds |
| 08/19/2004 | WO2004069239A1 Combination of antidiabetic drugs |
| 08/19/2004 | WO2004069238A1 Drug for improving prognosis for subarachnoid hemorrhage |
| 08/19/2004 | WO2004069237A1 Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis |
| 08/19/2004 | WO2004069236A1 Inhibitor for perioperative blood sugar elevation |
| 08/19/2004 | WO2004069235A1 The use of sodium 2-mercaptoethanesulfonate as antiviral agent |
| 08/19/2004 | WO2004069234A1 Pharmaceutical compositions and process of production thereof |
| 08/19/2004 | WO2004069233A1 Breast cancer-resistant protein inhibitor |
| 08/19/2004 | WO2004069232A2 Egfr tyrosine kinase inhibitor for treating cardiovascular dysfunction |
| 08/19/2004 | WO2004069230A1 Pharmaceutical compositions comprising an active agent and chitosan for sustained drug release or mucoadhesion |
| 08/19/2004 | WO2004069229A1 Dual release anti-diabetic drugs and process of production thereof |
| 08/19/2004 | WO2004069228A2 Sustained release formulations of venlafaxine |
| 08/19/2004 | WO2004069224A2 Stable sterile filterable liposomal encapsulated taxane and other antineoplastic drugs |
| 08/19/2004 | WO2004069223A2 Pharmaceutical compositions comprising immunosuppressants and uses thereof |
| 08/19/2004 | WO2004069217A1 Cosmetic composition based on cirsimarin |
| 08/19/2004 | WO2004069213A2 Cosmetic composition comprising a 2-alkylideneaminooxyacetamide |
| 08/19/2004 | WO2004069209A2 Compositions and methods for increasing the sensitivity of apoptosis-resistant tumor cells to inducers of apoptosis |
| 08/19/2004 | WO2004069203A2 Oral compositions of fenretinide having increased bioavailability and methods of using the same |
| 08/19/2004 | WO2004069202A2 Antiglucocorticoids for the treatment of postpartum psychosis |
| 08/19/2004 | WO2004069201A2 Compounds useful in coating stents to prevent and treat stenosis and restenosis |
| 08/19/2004 | WO2004069198A2 Sugar-free oral transmucosal solid dosage forms and uses thereof |
| 08/19/2004 | WO2004069196A2 Novel compounds |
| 08/19/2004 | WO2004069195A2 Methods and compositions for treating inflammatory disorders of the airways |
| 08/19/2004 | WO2004069192A2 Material and method for treating microbial mediated dermatological conditions |
| 08/19/2004 | WO2004069188A2 Methods for treatment of ibs and nud |
| 08/19/2004 | WO2004069187A2 Drug formulation and delivery using crystalline methylated cyclodextrins |
| 08/19/2004 | WO2004069186A2 Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin |
| 08/19/2004 | WO2004069181A2 Composition for the treatment of intraocular pressure |
| 08/19/2004 | WO2004069175A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF PARKINSON’S DISEASE AND OTHER α-SYNUCLEINOPATHIES |
| 08/19/2004 | WO2004069173A2 Methods for modulating an inflammatory response |
| 08/19/2004 | WO2004069168A2 Novel antiherpes drug combinations |
| 08/19/2004 | WO2004069167A2 Method and compositions for treating male infertility |
| 08/19/2004 | WO2004069166A2 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 08/19/2004 | WO2004069161A2 Polycosanols from ericerus pela wax |
| 08/19/2004 | WO2004069160A2 Chemical compounds |
| 08/19/2004 | WO2004069157A2 Combinational use of long-acting and short-acting anti-histamines for ocular allergies |
| 08/19/2004 | WO2004069156A2 Inactivated probiotic bacteria and methods of use thereof |
| 08/19/2004 | WO2004069155A2 Pharmaceutical composition of 1-(3-hydroxy-4-methoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5h-2,3-benzodiazepine and uses therof |
| 08/19/2004 | WO2004069150A2 Oils enriched with diacylglycerols and phytosterol esters for use in the reduction of cholesterol and triglycerides |
| 08/19/2004 | WO2004069149A2 Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof |
| 08/19/2004 | WO2004069143A2 Treatment of inflammatory bowel disease |
| 08/19/2004 | WO2004069142A2 Anti-candida agents for the treatment of prion diseases |
| 08/19/2004 | WO2004069141A2 Transdermal granisetron |
| 08/19/2004 | WO2004069133A2 N-monoacylated o-phenylenediamines as anti -cancer agents |
| 08/19/2004 | WO2004069029A2 Prevention of surgical adhesions using selective cox-2 inhibitors |
| 08/19/2004 | WO2004068971A1 Chitosan foodstuff |
| 08/19/2004 | WO2004068969A1 Enteral composition for the prevention and/or treatment of sepsis |
| 08/19/2004 | WO2004061408A3 Use of a non-specific inhibitor of the 5ht2b receptor for the treatment of prostate cancer |
| 08/19/2004 | WO2004060390A3 Use of a specific inhibitor of the 5ht2b receptor for the treatment of cancer |
| 08/19/2004 | WO2004058755A3 Compound libraries of imidazo[1,5-a]pyridin-3-yl derivatives and related heterobicycles for targetting compounds capable of binding to g-protein coupled receptors |
| 08/19/2004 | WO2004058720A3 Compound libraries of 1,3,5-substitute indazole derivatives as compounds for targetting compounds capable of binding to the g-protein coupled receptor |
| 08/19/2004 | WO2004058170A9 Methods for treating malaria by modulation of g protein function |
| 08/19/2004 | WO2004057950A3 Liposomal analgesic formulation and use |
| 08/19/2004 | WO2004056763A3 Novel glucagon antagonists |
| 08/19/2004 | WO2004056337A3 Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats |
| 08/19/2004 | WO2004054973A3 Piperidine and pyrrolidine derivatives as antagonists of histamine h3 receptor |
| 08/19/2004 | WO2004053067A3 Methods for inhibiting cancer and scar formation |
| 08/19/2004 | WO2004052371A3 Cyclic quinoline compounds for use in mch receptor related disorders |
| 08/19/2004 | WO2004052370A3 Quinoline compounds for use in mch receptor related disorders |
| 08/19/2004 | WO2004050678A3 Compounds resistant to metabolic deactivation and methods of use |
| 08/19/2004 | WO2004048335A3 Mandelic acid derivatives |
| 08/19/2004 | WO2004047839A8 High concentration formulations of opioids and opioid derivatives |
| 08/19/2004 | WO2004047830A3 Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitor and the use of said composition for treating bladder dysfunction |
| 08/19/2004 | WO2004047801A3 Method of drug loading in liposomes by gradient |
| 08/19/2004 | WO2004047732A3 Tocopherol and tocotrienol medicaments |
| 08/19/2004 | WO2004047729A3 Composition for the prevention and treatment of inflammation of the ear |
| 08/19/2004 | WO2004046196A3 Compositions and methods for treating bacterial infections with protein-dalbavancin complexes |
| 08/19/2004 | WO2004045629A8 Polyionenes for treating infections associated with cystic fibrosis |
| 08/19/2004 | WO2004041201A3 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 08/19/2004 | WO2004041195A3 Pharmaceutical formulations targeting specific regions of the gastrointestinal tract |
| 08/19/2004 | WO2004037172A3 Selenium bromide-oil-epichlorohydrin reaction products |
| 08/19/2004 | WO2004032716A9 Compounds for modulation of cholesterol transport |
| 08/19/2004 | WO2004024150A3 Mglu receptors antagonists for treating disorders associated with mglu receptors including addiction and depression |
| 08/19/2004 | WO2004024076A9 Novel compositions and methods for the treatment of immune related diseases |
| 08/19/2004 | WO2004019912A3 Buccal, polar or non-polar spray or capsule containing drugs for treating an infectious disease or cancer |
| 08/19/2004 | WO2004016805A9 Immunostimulatory nucleic acids |
| 08/19/2004 | WO2004002429A3 Methods of inhibiting pin1-associated states using a fredericamycin a compound |
| 08/19/2004 | WO2004002409A3 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 08/19/2004 | WO2003094853A3 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
| 08/19/2004 | WO2003092688A3 Heterocyclic derivatives as opioid modulators |
| 08/19/2004 | WO2003092585A3 Controlled release compositions of estradiol metabolites |
| 08/19/2004 | WO2003088958A3 Combinations of cox-2 inhibitors and other agents for the treatment of parkinson’s disease |
| 08/19/2004 | WO2003087316A3 Novel derivatives of carnosic acid |
| 08/19/2004 | WO2003083067A8 Histone deacetylase inhibitors for the treatment of multiple sclerosis, amyotrophic lateral sclerosis and alzheimer's disease |
| 08/19/2004 | WO2003077834A3 Central airway administration for systemic delivery of therapeutics |